Animal models of heart failure with preserved ejection fraction - Wikidata - awgldk - TriplyDB

Animal models of heart failure with preserved ejection fraction

Animal models of heart failure with preserved ejection fraction

http://www.wikidata.org/entity/Q26764971

about

Systems Medicine as an Emerging Tool for Cardiovascular Genetics Mitochondria and oxidative stress in heart aging NVVC/NHJ Durrer prizes 2016 Early-stage heart failure with preserved ejection fraction in the pig: a cardiovascular magnetic resonance study.Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes.Molecular Approaches in HFpEF: MicroRNAs and iPSC-Derived Cardiomyocytes.Heart failure with preserved ejection fraction: current status and challenges for the future.A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function.An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology.Skeletal muscle alterations in HFrEF vs. HFpEF.Comparison of speckle-tracking echocardiography with invasive hemodynamics for the detection of characteristic cardiac dysfunction in type-1 and type-2 diabetic rat models.Murine Models of Heart Failure with Preserved Ejection Fraction: a "Fishing Expedition".Heart Failure in Patients with Preserved Ejection Fraction: Questions Concerning Clinical Progression.In vivo quantification of myocardial stiffness in hypertensive porcine hearts using MR elastography.Why Don't We Have Proven Treatments for HFpEF?Nitric oxide-sensitive guanylyl cyclase stimulation improves experimental heart failure with preserved ejection fraction.Type-2 diabetic aldehyde dehydrogenase 2 mutant mice (ALDH 2*2) exhibiting heart failure with preserved ejection fraction phenotype can be determined by exercise stress echocardiography.Modelling the complexity of heart failure with preserved ejection fraction.Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.Genetic and Tissue Engineering Approaches to Modeling the Mechanics of Human Heart Failure for Drug Discovery

P2860

Q28069197-1B69B62F-4BB3-4FF7-9991-EAA420841ABD Q28391449-C9DC32E7-9D20-42F0-ACB2-C17AA20C6EA1 Q33603119-D80570B8-A753-4848-94FF-4D5241350934 Q37299336-4C7D8683-75A6-4790-8701-E761B2ECFD9B Q37696624-3F763864-BBAE-4B76-A84A-4A2EFF7774D2 Q39061922-FEB3C45C-C1FD-4458-9ACD-48DD58B8FA3B Q42948965-9484F513-97F0-4A2C-B75C-451905AAD5BB Q47105229-947A158C-26CC-4F74-BA86-65488E8A5246 Q47338830-71FFA634-2B07-4545-B8B6-AB189D671847 Q47937684-297E7A5B-3DEB-49C8-ADF9-5EF50F487E3A Q48232834-4E28F7FD-CDEB-483C-8FCB-71EE139CBFD7 Q49203906-40F05C8A-9E15-4122-B28D-6C427DFEBE6C Q49204428-63B43639-2CD2-4882-BBE3-31406F03565D Q51183824-3306010A-494D-4616-821C-1A33916A7FB3 Q51828593-F089E793-2AF0-4A16-A724-02E680CE69CF Q52375176-E9246DA3-B6D4-4480-9705-CACEB0383AFA Q55014723-BAF8185D-B71C-49A2-AC02-85A0E63FBEC1 Q55097804-4DCFDF58-6622-42ED-BC0C-05F08D5F15FE Q55431118-D4BC5063-8B3B-4EAB-9ABA-6BBB6287DC62 Q57072496-D9977038-D080-42FF-8577-282532B979D9

P2860

Animal models of heart failure with preserved ejection fraction

http://www.wikidata.org/entity/Q26764971

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Animal models of heart failure with preserved ejection fraction

@ast

Animal models of heart failure with preserved ejection fraction

@en

Animal models of heart failure with preserved ejection fraction

@nl

type

label

Animal models of heart failure with preserved ejection fraction

@ast

Animal models of heart failure with preserved ejection fraction

@en

Animal models of heart failure with preserved ejection fraction

@nl

prefLabel

Animal models of heart failure with preserved ejection fraction

@ast

Animal models of heart failure with preserved ejection fraction

@en

Animal models of heart failure with preserved ejection fraction

@nl

P1433

Q26764971-7ABB3C05-CE17-471D-B7EC-CA62B44013B0

P1476

Q26764971-62CFEBC5-F823-438B-B585-4F650BE56E2F

P2093

Q26764971-D2970158-2F62-4DF6-B677-9C287A6DB3F0

Q26764971-F92D2377-7A58-4CD5-96B2-1CF9C500AAAE

P2860

Q26764971-2143F26F-4695-4F2B-86B7-F127B30DB377

Q26764971-26118AD4-6DE7-4C7F-828A-1C5D7C87F4BE

Q26764971-30286B3B-4A08-449D-B004-926B8D280B47

Q26764971-377D7CA2-D0D4-4BA8-B17C-AB3C94125BDE

Q26764971-3B4BBD38-CB26-4DFF-838D-D0FE68CED90C

Q26764971-55C67044-A88E-4F79-8CE6-924E98780260

Q26764971-57AEFF20-1470-4398-B519-655150179E6D

Q26764971-5D080E57-D5BB-4E9E-8930-281B807DC015

Q26764971-5E598F80-9560-4DBB-871B-32DF5D40E850

Q26764971-697876B8-2D73-4861-82DA-4F11F5F30F28

P2888

Q26764971-F6EC9691-8189-462D-92CB-94613E4C5752

P304

Q26764971-641C94FB-9FDC-49C4-9916-8A6CA942DE77

P31

Q26764971-F1E553EE-D3D3-4BC1-BE73-5A433D0875A8

P3181

Q26764971-9E579F10-0EA4-4563-91C9-954DB099141D

P356

Q26764971-00DD2069-B62E-4A93-8F86-EE028DF3D431

P407

Q26764971-EA741D58-1234-4862-91C8-8ED7C7822232

P433

Q26764971-8BFD2675-8B8A-4D1A-A757-8CB3426BAFAC

P478

Q26764971-2A07333E-C264-4597-9B74-12D3DBE03853

P50

Q26764971-1A671B2F-B09D-45FB-B341-B7EFAE10FE26

Q26764971-4F284004-739F-4959-A4EB-EC4D3DB1FDF8

Q26764971-B1591EDF-6B12-406D-BC39-6AD898C8F26E

P577

Q26764971-214B133E-863F-4D11-BEA1-B0395BA4737B

P5875

Q26764971-37AC81C6-CFCB-468F-9395-521A61C2D51C

P6179

Q26764971-9AC9247E-1D5D-4F47-A816-7427CE25A7EB

P698

Q26764971-BB4F63F7-538D-44CE-A0F1-52837FE5E94B

P921

Q26764971-DB4D7619-75D4-4CA4-940B-F4F4BE953E07

P932

Q26764971-0D57C131-96F1-4BC2-AAFD-F0B1E9870164

P3181

P356

S12471-016-0815-9

P1433

Netherlands Heart Journal

P1476

Animal models of heart failure with preserved ejection fraction

@en

P2093

D J Duncker

http://www.w3.org/2001/XMLSchema#string

I Heinonen

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetic cardiomyopathy: bench to bedside

Trends in prevalence and outcome of heart failure with preserved ejection fraction

Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity

Diastolic dysfunction in spontaneous type 2 diabetes rhesus monkeys: a study using echocardiography and magnetic resonance imaging.

Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via "nongenomic effects".

Epidemiology and clinical course of heart failure with preserved ejection fraction

Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment

Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.

An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.

Diastolic dysfunction is associated with cardiac fibrosis in the senescence-accelerated mouse

P2888

s12471-016-0815-9

P304

275-286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3253814

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S12471-016-0815-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

André P. Lourenço

Inês Falcão-Pires

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

296693749

http://www.w3.org/2001/XMLSchema#string

P6179

1026726674

http://www.w3.org/2001/XMLSchema#string

P698

26936157

http://www.w3.org/2001/XMLSchema#string

P921

P932

4796054

http://www.w3.org/2001/XMLSchema#string